ArticleBritish journal of cancer2024

CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.

Razia Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.